Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 9,009 shares at $16.75 ($151K) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Open-market sale of $151k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.15 | 11 | $167 | 0.1% |
| 2 | $16.75 | 4,499 | $75K | 49.9% |
| 3 | $16.75 | 4,499 | $75K | 49.9% |
| Total | $16.75 avg | 9,009 | $151K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |